Lipid manufacturing at Evonik: Facilities and capabilities

Overview

Lipids are one of the pillar excipients for drug delivery systems and are especially important for RNA-based therapies such as mRNA vaccines. As a CDMO partner offering end-to-end solutions, Evonik has built up a body of experience and expertise in every step of the manufacturing process such as route scouting, process development, optimization, purification, isolation, characterization, scale-up and commercialization.

In this webinar, our experts will introduce Evonik’s new Lipid Launch Facility in Hanau, Germany, and talk through each of these important steps in detail outlining key capabilities for success. Solutions to common challenges are also addressed in this webinar.

Key learnings for participants:

Explanation of analytical capabilities to support lipid development and manufacturing
Insight into project execution at Evonik
Introduction to Evonik’s new Lipid Launch Facility

Experts featuring this session

Dr. Ulrich Klöckner
Global Project Manager
Evonik Health Care
Vita

Dr. Ulrich Klöckner joined Evonik in 2017 and has held several R&D roles within the Evonik Health Care business. In his first positions as a laboratory head he was responsible for the process development and scale up of APIs and lipids. As a project manager in the CDMO business, he managed and led projects focusing on APIs and lipids manufacturing under cGMP.

Since 2022, as a global project manager, Ulrich is responsible for the project management and serves as the technical contact of Evonik Health Care’s lipid business. Ulrich is an organic chemist by education and obtained his PhD from the University of Tuebingen in Germany. As a postdoctoral fellow, holding a DFG scholarship, he went to the University of Urbana Champaign in Illinois, USA. Ulrich is author of numerous research papers and patent applications.

Dr. Lauren Longobardi
Global Project Manager
Evonik Health Care
Vita

Dr. Lauren Longobardi joined Evonik in 2019 and, since 2021, has been a global project manager within Evonik’s Health Care business line.

In her previous position, Lauren worked as an R&D lab head, where she gained experience in chemical route scouting, process development, and scale-up manufacturing of pharmaceutical ingredients.

Lauren was trained as a synthetic inorganic chemist. She received her Ph.D. from the University of Toronto in Canada, where she focused on FLP small molecule activation and the synthesis of novel heterocyclic compounds. She then moved to Germany in 2017 for her postdoctoral studies at the Max-Planck-Institut für Kohlenforschung before starting her career at Evonik.

Related webinars in this series

This is the second webinar of our three-part webinar series entitled "Lipids in Focus: Unleashing the Power of RNA Therapeutics".

To learn more about the two other webinars in this series please click on the respective webinar below. To register for multiple webinars of this series simply select them in the registration form.